Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Invesco NASDAQ 100 ETF — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Invesco NASDAQ 100 ETF trades at $296.46 (market cap $111.60B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 15.7× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Invesco NASDAQ 100 ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Invesco NASDAQ 100 ETF for 56 Days on average.
| IONS | QQQM | |
|---|---|---|
Market Cap | $7.10B | $111.60B |
Volume | 2,027,457 | 3,716,107 |
Sector | Health | Broad Market / Factor |
52-Week High | $86.50 | $312.76 |
52-Week Low | $42.38 | $229.87 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $6.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQM trades at $306.18, down 0.33% on the day, with a bullish technical signal from moving averages while oscillators remain neutral. The ETF maintains its focus on Nasdaq-100 exposure with a competitive 0.15% expense ratio. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% during Q2 2026, signaling confidence in the fund's strategy.
The outlook remains positive given the Nasdaq-100's strong performance and institutional accumulation, though risks include market concentration in technology stocks and potential volatility. The fund's lower fees compared to QQQ provide a structural advantage for long-term investors seeking Nasdaq exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
